UNSPSC 51412401: Carbocromen or chromonar

This classification denotes a vasodilating agent with the molecular formula C20H27NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R0C9NIE5JJ, chemically known as acetic acid, ((3-(2-(diethylamino)ethyl)-4-methyl-2-oxo-2h-1-benzopyran-7-yl)oxy)-, ethyl ester but generally known as carbocromen, which bears US NIH Compound Identifier 12604. Carbocromen most often comes in base and hydrochloride forms.

UNSPSC 51412401 Carbocromen or chromonar is a Commodity code under which state and local governments procure advanced cardiovascular and emergency-response medications for use by fire rescue services, public health agencies, and multistate cooperative purchasing programs. Recent solicitations show purchasing of specific pharmaceutical formulations—epinephrine, labetalol, adenosine, and diltiazem preparations—supplied in measured units with strict expiration-date and shelf-life requirements, alongside broader generic pharmaceutical and over-the-counter product sourcing through cooperative agreements. The issuing bodies include city purchasing departments (Tampa), state health agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). Work encompasses both direct goods procurement for emergency medical services and market-intelligence gathering to establish direct manufacturer-to-state contracting relationships outside traditional pharmacy benefit manager and group purchasing organization channels.

Activity spans Florida, Texas, Minnesota, and Oregon. The City of Tampa's Purchasing Department issued an IFB (Bid No. 26P00188) for Advanced Life Support Medications on April 24, 2026, with a due date of April 8, 2026 and an estimated contract value of $40,000, requiring sealed bids for four medication line items (labetalol, epinephrine, adenosine, and diltiazem) to supply Tampa Fire Rescue with nine-month-plus expiration dates and ten-day delivery; the solicitation carried a Small Local Business Enterprise sheltered market designation with a 5 percent bid discount not to exceed $10,000. The Minnesota Department of Administration's Office of State Procurement, administering the MMCAP cooperative, issued an RFP (S1070000015802) on January 20, 2026, with a response deadline of March 26, 2026, for generic multi-source pharmaceuticals and OTC products to be distributed across state and local facilities in Minnesota and Oregon, requiring vendors to maintain relationships with three authorized wholesalers and comply with cGMP and Drug Supply Chain Security Act standards. The Texas Health and Human Services Commission issued an RFI (HHS0017013) on April 3, 2026, seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, representing early-stage market research prior to formal RFP issuance.